Xiantan Co., Ltd. has fully resumed production and production. Last year’s performance increased by 1 with the chicken.48 times

Xiantan Co., Ltd. has fully resumed production and production. Last year’s performance increased by 1 with the chicken.48 times
On the evening of March 23, Xiantan issued its 2019 annual report.In 2019, Xiantan Co., Ltd. achieved operating income of approximately 35.3.3 billion yuan, an increase of 37 from the same period in 2018.07%; net profit attributable to shareholders of listed companies is about 1 billion, an increase of 148 over the same period in 2018.95%; the net profit attributable to shareholders of the listed company is about 9.3.6 billion yuan, an increase of 163 over the same period in 2018.65%.The main business of Xiantan Stock Company is the breeding of broiler breeders for parents, hatching of chicks, feed production, breeding and slaughter of commercial broilers, processing and sales of chicken products.The company’s main products are commercial broiler chicken and chicken products, of which chicken products are mainly sold in the form of divided frozen chicken products, chilled chicken products and prepared foods. In 2019, the supply of domestic white-feather broiler markets continues to be tight. In the case of a shortage of domestic introductions, the stock of parent breeder chickens continues to decline, resulting in high prices of parent broiler breeder chickens and commercial broiler chickens.The strong consumer demand for chicken products, coupled with the impact of the African swine fever incident, continues to increase the alternative consumer demand for chicken, and many factors are superimposed, so the entire white feather broiler industry continued the boom in 2018.”In the report, the supply of white feather broilers is tight, consumer demand is strong, the industry is booming, and the company’s chicken product sales prices have increased, resulting in an increase in the company’s operating results in 2019 compared with the same period last year.”Xiantan shares said.Along with the growth in performance, Xiantan’s share price rose last year.Data from Choice Financial Terminal shows that in 2019, the total market value of Xiantan’s shares will increase by about 29.9.1 billion yuan.In this new coronary pneumonia epidemic, Xiantan said that it has “not been significantly affected.” “The company is located in a non-severe epidemic area of the new coronary disease. According to the State Council’s response to the new coronavirus infection pneumonia joint prevention and control mechanism and the Shandong Provincial Committee’s new crownThe Office of the Leading Group (Command Headquarters) of the Virus Infection Pneumonia Disposal Work Office, “Regarding the Effective Strengthening of the Scientific Prevention and Control of the Epidemic, Orderly Doing a Good Job in Enterprise Resumption and Resumption of Production” and other relevant requirements, the company and its subsidiaries have now fully resumed production.”Sauna, Night Net Yan Xia Editor Yue Caizhou Proofreading Liu Baoqing